Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Vascular Defect in Macular Sickle Cell Maculopathy by OCT-A

NCT07877753 is registered in ClinicalTrials.gov with Christophe Orssaud as lead sponsor.

NCT NCT07877753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07877753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Vascular Defect in Macular Sickle Cell Maculopathy by OCT-A
Lead sponsor
Christophe Orssaud
Phase
Observational
Overall status
Completed
Start date
September 1, 2026
Completion date
October 1, 2026
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macula abnormality, macula thickening, sickle cell disease